• 대한방사선기술학회지:방사선기술과학
• /
• 제30권4호
• /
• pp.365-371
• /
• 2007

최근 연구들은 골다공증과 동맥경화증의 병인 간의 연관성을 제시한다. 이 연구에서는 건강한 중년 여성에서 high-sensitivity C-reactive protein(hs-CRP), 지질 농도 등을 포함한 심혈관 위험인자들과 요추 골밀도의 상관관계를 분석하였다. 총 300명의 성인여성을 대상으로 하여 신체계측을 시행하였고, 공복혈당, 지질, hs-CRP를 포함한 심혈관질환 위험인자들을 측정하였다. 동맥경화지수는 총콜레스테롤 농도를 고밀도지단백 콜레스테롤 농도로 나누어서 계산하였다. Dual X-ray abosorptiometry를 이용하여 요추 골밀도를 측정하였다. 연구결과 연령, 수축기 및 이완기 혈압, 총 콜레스테롤, 고밀도지단백 콜레스테롤은 요추 골밀도와 음의 상관관계를 보였다. 통계적으로는 연령과 체질량지수, 고밀도지단백 콜레스테롤이 요추 골밀도와 의미 있는 상관관계를 보였다. 요추 골밀도에 영향을 미치는 심혈관 인자들은 연령과 고밀도지단백 콜레스테롤이 요추 골밀도($R^2=0.272$)의 독립적 위험인자로 나타났다.

• 근관절건강학회지
• /
• 제15권2호
• /
• pp.166-174
• /
• 2008

Purpose: The purpose of this study was to examine the effect of a 8-week dynamic yoga program on body composition and blood lipids in middle-aged post-menopausal women. Method: Twenty participants were allocated to the yoga group (YG, n=10) or the control group (CG, n=10). They were assessed for lean body mass, percent body fat, waist to hip ratio, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglyceride both before and after intervention. The yoga group participated in the program lasting $50{\sim}60$ minutes, five times a week for 8 weeks. Results: Unlike the control group, the yoga group showed a significant decrease in total cholesterol, low density lipoprotein cholesterol, percent body fat, and waist hip ratio after the yoga training. However, changes in lean body mass, high density lipoprotein cholesterol, and triglyceride level during the intervention period were not different between the yoga group and the control group. Conclusion: The 8-week dynamic yoga program could be adopted to prevent cardiovascular diseases in middle-aged post-menopausal women by promoting body composition & blood lipids.

• 한국식품영양학회지
• /
• 제26권3호
• /
• pp.526-534
• /
• 2013

This study was conducted to examine the effects of Opuntia ficus-indica complex (OF) on the lipid metabolism, bile acid in feces, alanine aminotransferase (ALT) activity, aspatate aminotransferase (AST) activity, composition of urine and expression of cholesterol related mRNA in streptozotocin (STZ)-induced diabetic rats. Thirty two male Sprague-Dawley rats were randomly divided into non-diabetic control (NC), diabetic control (DC), diabetic OF of 2% (OF-2) and diabetic OF of 5% (OF-5), then each group was fed for 3 weeks. Plasma total cholesterol, non-esterified fatty acids (NEFA), total cholesterol, low density lipoprotein (LDL), very low density lipoprotein (VLDL) were decreased significantly (p<0.05) in OF-5 group compared to DC, but high density lipoprotein (HDL) was not changed. AST and ALT were also reduced and bile acid excretion was improved. Composition of urine in OF-5 was almost same in NC. The expression of cholesterol $7{\alpha}$-hydroxylase (CYP7A1), 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA-R), Low density lipoprotein receptor (LDL-R) mRNA indicated that feeding OF have the effects of cholesterol decreation in plasma by synthesis of bile acid from cholesterol. These results provide experimental evidence about improved lipid metabolism of the OF feeding in the STZ-induced diabetic rats.

• 보건행정학회지
• /
• 제9권3호
• /
• pp.70-94
• /
• 1999

This paper was performed for a cost-effectiveness analysis of pharmacologic treatment of hypercholesterolemia. Agents modeled were cholestyramine, gemfibrozil. bezafibrate, lovastatin, pravastatin, simvastatin. Pharmacologic effectiveness was estimated by regression from reported clinical trials. Pharmacologic effects were expressed as the percent change of blood cholesterol level. Cost estimates included patients' travel expenses and time loss as well as resource consumption in the health care sector. Bezafibrate was the most efficient agent for reducing total cholesterol levels, having an cost over 1 year of ￦31.400 per percent reduction in total cholesterol. Simvastatin (10mg/d) was also efficient(￦33,100 per percent reduction). Chole styramine(8g/d) was least efficient at ￦90,200. For low-density lipoprotein cholesterol. simvastatin(10mg/d) was most efficient, at ￦23,200 per percent reduction, followed by lovastatin(20mg/d) at ￦28,000. Gemfibrozil was least efficient at ￦77,800 per percent reduction. For high-density lipoprotein cholesterol. bezafibrate(400mg/d) was most efficient at ￦39,300 per percent increase of high-density lipoprotein cholesterol. Cholestyramine was least efficient at ￦514,700. Analyses combining low-density lipoprotein cholesterol and high-density cholesterol effects suggest that bezafibrate(600mg/d) and simvastatin (10mg/d) were most efficient for reducing cardiovascular risk. The cost-effectiveness analysis results show that both simvastatin and bezafibrate could be efficient treatment. Simvastatin provide more effective treatment at higher cost, whereas bezafibrate is more cost-effective, as it may be less effective, at lower cost. Therefore, clinicians should choose reasonable treatment according to the patient's needs This pharmacoeconimc analysis will provide a guideline for efficient pharmacologic treatment and also be reference data for pricing new drugs.

• Childhood Kidney Diseases
• /
• 제26권1호
• /
• pp.25-30
• /
• 2022

Dyslipidemia in nephrotic syndrome (NS) is often characterized by marked increases in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and other lipoproteins, such as very low-density lipoprotein, intermediate-density lipoprotein, and lipoprotein(a). It has been suggested that impaired catabolism of lipoproteins and cholesterol is mainly due to decreased lipoprotein lipase and hepatic lipase activity, and increased biosynthesis of lipoproteins in the liver. The management strategies for dyslipidemia in patients with NS consist of lifestyle modification, lipid-lowering agents represented by statins, second-line agents such as fibrates and bile acid sequestrants, and lipid apheresis. Compared with dyslipidemia in adult NS patients, whose risks of atherosclerotic disease and progressive renal injury are considered high, clinical data on dyslipidemia in pediatric NS patients are limited. Therefore, it is necessary to pay more attention to the evaluation and management of dyslipidemia in pediatric patients with NS in clinical practice.

• 대한의생명과학회지
• /
• 제20권4호
• /
• pp.221-226
• /
• 2014

High-density lipoprotein (HDL) cholesterol levels are associated with decreased risk of coronary artery disease. Several genome-wide association studies (GWAS) for HDL cholesterol levels have implicated Lipoprotein lipase (LPL) as possibly being causal. Herein, the association between single nucleotide polymorphism (SNP) rs10503669 in the LPL gene and HDL cholesterol levels and triglyceride levels was tested in the Korean population. A total of 994 subjects from Seoul City were included in a replication study with LPL SNP rs10503669. SNP rs10503669 in the LPL gene was associated with mean HDL cholesterol levels (effect per allele 3.13 mg/dL, P<0.0001) and triglyceride levels (effect per allele -18.0 mg/dL, P=0.0026). Subjects with the CA/AA genotype had a 0.42-fold (range 0.23~0.77-fold) lower risk of having abnormal HDL cholesterol levels (<40 mg/dL) than subjects with the CC genotype. When analyzed by gender, the association of LPL was stronger in men than in women. This study clearly demonstrates that genetic variants in LPL influence HDL cholesterol levels and triglyceride levels in Korean adults.

• The Korean Journal of Physiology
• /
• 제16권2호
• /
• pp.195-207
• /
• 1982

장기적(長期的)인 채식섭취(菜食攝取)가 혈청(血淸)의 lipoprotein, cholesterol 및 단백량(蛋白量)에 미치는 영향(影響)을 알아보기 위하여 결은 여승(女僧) 45명(名)($20{\sim}35$세)과 대조군(對照群)으로 여대생(女大生) 29명(名)($20{\sim}22$세)을 연구대상(硏究對象)으로 하였다. 하루 열량섭취(熱量攝取)는 여승(女憎)들이 1,945 kcal 였고 여대생(女大生)은 1,815 kcal 였다. 열량구성비율(熱量構成比率)은 여승(女僧)들이 탄수화물(炭水化物) : 단백질(蛋白質) : 지방(地方)=84 : 11 : 5였고 학생(學生)은 70 : 15 : 15였으며 이는 여승(女僧)들의 탄수화물(炭水化物) 편중(偏重) 및 지방섭취부족(脂肪攝取不足)을 보여준다. 신체계측결과(身體計測結果) 여승(女僧)들은 여대생(女大生)보다 신장(身長)을 제외(除朴)하고, 체중(體重), 지방층(脂肪層)두께, 체표면적(體表面積) 및 비만도계수(肥滿度係數)가 모두 높았다. 수축기(收縮期) 및 이완기혈압(弛緩期血壓)은 여승(女憎)과 여대생(女大生)이 거의 같았다. 혈청(血淸)의 총지방(總脂肪), cholesterol 및 단백량(蛋白量)은 여승(女憎)과 여대생간(女大生間)에 유의(有意)한 차이(差異)가 없었다. 그러나 전기영동(電氣泳動)으로 분획(分劃)하여 혈청(血淸)의 high density lipoprotein(HDL), very low density lipoprotein(VLDL) 및 low density lipoprotein(LDL)량(量)을 비교(比較)해 본 결과(結果), 여승(女憎)들의 HDL은 여대생(女大生)보다 낮았으나 LDL은 유의(有意)하게 높았다. Cholesterol분획결과(分劃結果)도 역시 여승(女憎)들의 HDL-cholesterol값은 여대생(女大生)보다 유의(有意) 하게 낮은 반면(反面) LDL-cholesterol은 유의(有意)하게 높았다. Lipoprotein과 cholesterol간(間)의 상관계수(相關係數)(r)를 계산(計算)한 결과(結果) LDL과 LDL-cholesterol(r=0.40), VLDL과 VLDL-cholesterol(r=0.85), HDL과 HDL-cholesterol(r=0.45), 혈청총지방량(血淸總脂防量)과 cholesterol(r=0.66) 및 혈청(血淸) 총(總) cholesterol과 LDL-cholesterol(r=0.79) 간(間)에는 유의(有意)한 상관관계(相關關係)를 보여주었다. 그러나 혈청(血淸) cholesterol과 음식섭취(飮食攝取) 및 신체계측결과간(身體計測結果間)에는 유의(有意)한 상관관계(相關關係)가 나타나지 않았다. 혈청단백량(血淸蛋白量)은 여승(女憎)과 여대생간(女大生間)에 차이(差異)가 없었다. 이상(以上)의 결과(結果)는 여승(女憎)들의 장기적(長期的)인 채식섭취(菜食攝取)로 인(因)해 인체(人體)의 lipoprotein 및 cholesterol 대사(代謝)에 영향(影響)이 있음을 시사(示唆)해 주고 있다.

• Journal of Ginseng Research
• /
• 제10권1호
• /
• pp.114-121
• /
• 1986

고려 인삼 뿌리에서 얻은 사포닌 분획이 고cholesterol 식이로 2주내지 4주간 사육한 토끼의 혈청 지단백질 분포에 미치는 영향을 조사하였다. 고cholesterol 식이를 인삼과 함께(시험군) 또는 단독(대조군)으로 2~4주간 투여한 토끼의 혈청 극저밀도 지단백질(VLDL)과 저밀도 지단백질(LDL)이 다같이 크게 증가하는 반면 고밀도 지단백질(HDL)의 농도는 저하 하였다. 그러나 VLDL과 LDL 농도의 증가율이나 HDL 농도의 저하율은 인삼을 투여한 토끼군에서 현저히 적었으며 인삼사포닌의 고cholesterol 혈증 개선작용이 VLDL의 LDL 농도를 낮추고 HDL의 농도를 높이기 때문인 것으로 생각된다.

• Nutrition Research and Practice
• /
• 제12권4호
• /
• pp.298-306
• /
• 2018

BACKGROUND/OBJECTIVES: Obesity is a global health problem of significant importance which increases mortality. In place of anti-obesity drugs, natural products are being developed as alternative therapeutic materials. In this study, we investigated the effect of Brassica juncea L. leaf extract (BLE) on fat deposition and lipid profiles in high-fat, high-cholesterol diet (HFC)-induced obese rats. MATERIALS/METHODS: Male Sprague-Dawley rats were divided into four groups (n = 8 per group) according to diet: normal diet group (ND), high-fat/high-cholesterol diet group (HFC), HFC with 3% BLE diet group (HFC-A1), and HFC with 5% BLE diet group (HFC-A2). Each group was fed for 6 weeks. Rat body and adipose tissue weights, serum biochemical parameters, and tissue lipid contents were determined. The expression levels of mRNA and proteins involved in lipid and cholesterol metabolism were determined by reverse transcription polymerase chain reaction and western blot analysis, respectively. RESULTS: The HFC-A2 group showed significantly lower body weight gain and food efficiency ratio than the HFC group. BLE supplementation caused mesenteric, epididymal, and total adipose tissue weights to decrease. The serum levels of triglyceride, total cholesterol, and low-density lipoprotein cholesterol were significantly reduced, and high-density lipoprotein cholesterol was significantly increased in rats fed BLE. These results were related to lower glucose-6-phosphate dehydrogenase, acetyl-coA carboxylase, and fatty acid synthase mRNA expression, and to higher expression of the cholesterol $7{\alpha}$-hydroxylase and low density lipoprotein-receptor, as well as increased protein levels of peroxisome proliferator-activated receptor ${\alpha}$. Histological analysis of the liver revealed decreased lipid droplets in HFC rats treated with BLE. CONCLUSIONS: Supplementation of HFC with 3% or 5% BLE inhibited body fat accumulation, improved lipid profiles, and modulated lipogenesis- and cholesterol metabolism-related gene and protein expression.

• Journal of Pharmaceutical Investigation
• /
• 제24권4호
• /
• pp.297-300
• /
• 1994

Development of hyperlipidemic animal model is prerequisite for the screening of drugs lowering the blood lipoprotein level. In this study, two kinds of diet regimens were tried for the hyperlipidemic effect. The model will be used for the screening of current prescriptions to a variety of diseases related to hyperlipidemia by practioner of traditional herbal medicine. Fifteen male Wister rats of 200g were divided into three groups, and given normal, or either one of the two high cholesterol diets for up to 2 weeks. Regimen HC-1 and regimen HC-2 contained I% and 2% cholesterol in diet, respectively. Total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL) and lower density lipoprotein cholesterol (LDL) levels in the serum were measured before the start of the diet, at 1 week after the start, and at 2 week point. Both regimens resulted in hyperlipidemia with the typical characteristics of increase in TC and LDL, and reduction in HDL, and showed no observable side effects such as diarrhea. In conclusion, both of HC-1 and HC-2 regimens appeared appropriate as diet regimens for the hyperlipidemic rat model.